Natera (NTRA) Net Income towards Common Stockholders Growth (1y) (2015 - 2026)
Natera (NTRA) Net Income towards Common Stockholders Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.96 Bn | 209.90 Bn | 8.34 Bn | 8.66% |
| 2 | Danaher | 140.29 Bn | 135.94 Bn | 3.61 Bn | 56.76% |
| 3 | Idexx Laboratories | 46.08 Bn | 45.88 Bn | 779.09 Mn | 15.11% |
| 4 | Agilent Technologies | 39.78 Bn | 37.97 Bn | 990.00 Mn | 57.67% |
| 5 | Iqvia Holdings | 39.43 Bn | 37.35 Bn | 1.44 Bn | -9.74% |
| 6 | Natera | 38.72 Bn | 37.62 Bn | 696.04 Mn | -27.15% |
| 7 | Illumina | 30.05 Bn | 28.88 Bn | 770.00 Mn | -11.91% |
| 8 | Mettler Toledo International | 28.63 Bn | 28.58 Bn | 650.22 Mn | 15.10% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | 12.89% |
| 10 | Labcorp Holdings | 25.89 Bn | 24.91 Bn | 1.01 Bn | 30.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.15% |
| Dec 31, 2025 | 187.88% |
| Sep 30, 2025 | -177.11% |
| Jun 30, 2025 | -169.49% |
| Mar 31, 2025 | 0.98% |
| Dec 31, 2024 | 31.11% |
| Sep 30, 2024 | 71.02% |
| Jun 30, 2024 | 66.19% |
| Mar 31, 2024 | 50.63% |
| Dec 31, 2023 | 45.25% |
| Sep 30, 2023 | 10.25% |
| Jun 30, 2023 | 23.66% |
| Mar 31, 2023 | 1.20% |
| Dec 31, 2022 | -1.43% |
| Sep 30, 2022 | 19.69% |
| Jun 30, 2022 | -25.10% |
| Mar 31, 2022 | -117.05% |
| Dec 31, 2021 | -83.96% |
| Sep 30, 2021 | -159.37% |
| Jun 30, 2021 | -94.55% |